Cargando…
Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel coronavirus, causes coronavirus disease 2019 (COVID‐19) which led to neurological damage and increased mortality worldwide in its second and third waves. It is associated with systemic inflammation, myocardial infarction, neurolog...
Autores principales: | Sarkar, Sibani, Karmakar, Subhajit, Basu, Malini, Ghosh, Pratyasha, Ghosh, Mrinal K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080216/ https://www.ncbi.nlm.nih.gov/pubmed/37035134 http://dx.doi.org/10.1002/mco2.247 |
Ejemplares similares
-
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
por: Kumar, Sunny, et al.
Publicado: (2023) -
The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports
por: Ghosh, Mrinal K., et al.
Publicado: (2019) -
Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
por: Kumar, Sunny, et al.
Publicado: (2022) -
COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape
por: Ghosh, Mrinal K, et al.
Publicado: (2023) -
Chaperone-assisted E3 ligase CHIP: A double agent in cancer
por: Kumar, Sunny, et al.
Publicado: (2021)